BOB体育

Skip to main content
(352) 273-6990

Ashley Ghiaseddin, MD : Research

Neuro-Oncologist (Brain Cancer Specialist)

Photo of Ashley Ghiaseddin
(352) 273-6990 MyUFHealth

Research at a glance

Top areas of exploration

  • Brain Neoplasms , 14 publications
  • Glioblastoma , 6 publications
  • Neoplasm Recurrence, Local , 3 publications
  • Glioma , 3 publications

Research activity

29 publications

272 citations

Why is this important?

Active clinical trials

OPTIMUS PRIME - Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa

In this study we are evaluating the safety and feasibility of the triple combination (TTFields, MLA, pembrolizumab) in adult patients diagnosed with recurrent or progressive glioblastoma (GBM) WHO Grade IV, IDH wild type or recurrent or progressive鈥�

Investigator
Ashley Ghiaseddin
Status
Accepting Candidates
Ages
18 Years - 90 Years
Sexes
All
EF-41/KEYNOTE

This is a multicenter, two-arm, randomized, double-blind, placebo-controlled study of Optune庐 (Tumor Treating Fields at 200 kHz) together with maintenance Temozolomide (TMZ) chemotherapy agent and pembrolizumab compared to Optune庐 together with鈥�

Investigator
Ashley Ghiaseddin
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

29 publications

2025

How do I prescribe and manage mIDH inhibitors in patients with IDH-mutant glioma?

Neuro-oncology practice

鈥�

2025

Opiate Use Patterns Following Surgery for High Grade Glioma

World Neurosurgery

2025

Predictive Power of the Fried Phenotype in Assessing Postoperative Outcomes in Patients Undergoing Craniotomy for Tumor Resection.

Neurosurgery

鈥�

2025

Safety and Efficacy of Ketorolac After Craniotomy for Tumor Resection

World Neurosurgery

2024

Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directions.

Neuro-oncology advances

鈥�